C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) A61P 35/02 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C12N 5/10 (2006.01) C12N 5/12 (2006.01) C12N 15/10 (2006.01) C12N 15/11 (2006.01) C12N 15/63 (2006.01) G01N 33/566 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2432036
The invention relates to a molecule, termed SC5 by the inventors, to an allelic form of p140, and to the biological applications of SC5 and p140 molecules, notably in the diagnosis and therapy of CTCL.
L'invention concerne une nouvelle molécule désignée SC5 par ses inventeurs, un nouvelle forme allélique de p140 et des applications biologiques des molécules SC5 et p140, notamment dans le diagnostic et la thérapie d'érythrodermie de type Sézary (CTCL).
Bagot Martine
Bensussan Armand
Boumselle Laurence
Moretta Allessandro
Institut National de La Sante Et de La Recherche Medicale (i.n.s
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Means for the diagnosis and therapy of ctcl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Means for the diagnosis and therapy of ctcl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means for the diagnosis and therapy of ctcl will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2000172